Evidence map›Paper›PMID 38136373›Full record

ReviewCancers2023

Imaging of Peritoneal Carcinomatosis in Advanced Ovarian Cancer: CT, MRI, Radiomic Features and Resectability Criteria.

Valentina Miceli, Marco Gennarini, Federica Tomao, Angelica Cupertino, Dario Lombardo, Innocenza Palaia, Federica Curti, Sandrine Riccardi, Roberta Ninkova, Francesca Maccioni and 4 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Imaging of Peritoneal Surface Malignancies.Journal of surgical oncology · 2024
    Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Valentina MiceliDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Marco GennariniDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Federica TomaoDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Angelica CupertinoDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Dario LombardoDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0009-0004-2310-5945
Innocenza PalaiaDepartment of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Federica CurtiDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Sandrine RiccardiDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Roberta NinkovaDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Francesca MaccioniDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Paolo RicciDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0000-0001-5212-0678
Carlo CatalanoDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Stefania Maria Rita RizzoClinica di Radiologia EOC, Istituto Imaging della Svizzera Italiana (IIMSI), 6900 Lugano, Switzerland.ORCID 0000-0002-5151-0866
Lucia ManganaroDepartment of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0000-0001-9037-9904
Sapienza University of Rome · ITIstituto Imaging della Svizzera Italiana

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PC represents the most striking picture of the loco-regional spread of ovarian cancer, configuring stage III. In the last few years, many papers have evaluated the role of imaging and therapeutic management in patients with ovarian cancer and PC. This paper summed up the literature on traditional approaches to the imaging of peritoneal carcinomatosis in advanced ovarian cancer, presenting classification systems, most frequent patterns, routes of spread and sites that are difficult to identify. The role of imaging in diagnosis was investigated, with particular attention to the reported sensitivity and specificity data-computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography-CT (PET-CT)-and to the peritoneal cancer index (PCI). In addition, we explored the therapeutic possibilities and radiomics applications that can impact management of patients with ovarian cancer. Careful staging is mandatory, and patient selection is one of the most important factors influencing complete cytoreduction (CCR) outcome: an accurate pre-operative imaging may allow selection of patients that may benefit most from primary cytoreductive surgery.

Indexed as

cytoreductionimagingovarian cancerperitoneal diseaseradiomic

Identifiers

PMID38136373
PMCPMC10741537
OpenAlexW4389672599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.